A local biotech company has filed for bankruptcy. Sangamo Therapeutics, based in the area, has taken this step. Details of the bankruptcy filing are available from business news sources. The company's assets are being split by partners Lilly and Astellas. Further information on the bankruptcy and asset split can be found through The Business Journals, which reported on the development.